Clinical Trial Update: Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine with oxaliplatin as second-line therapy for metastatic colorectal cancer; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Miami | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-02-26